Thursday, July 29, 2021 2:27:04 PM
To be clear, this is not a new development. These assays have been known for years to be unable to distinguish between the different types of coronaviruses, but they ran with it anyway. According to the CDC website [emphasis added]:
After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.
…
In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing.
Why the sudden change?
According to J.D. Rucker at The Liberty Daily:
The RT-PCR assays could detect the presence of a coronavirus from a swab in real-time, making it a good indicator of the potential for Covid-19 infection. In a sane world that wasn’t driven by a nefarious agenda, positive results on the RT-PCR tests would have been treated as indicators that someone needed to get a real test, like an antigen test, to determine if they were infected. But this isn’t a sane world and the powers-that-be saw an opportunity to bump up numbers to drive panic. They ran with it, and revoking the EUA means they’re done with that particular type of fearmongering. The RT-PCR assays served their purpose.
The other reason for this move is very concerning. This shift and its timing both indicate the powers-that-be are anticipating a need to differentiate between the various coronaviruses. If it really is the need to differentiate Covid-19 and influenza as they’re claiming, then that jibes with the sudden push to maximize or even mandate flu vaccines within months. If that’s the scenario they have planned, expect a sudden surge in flu cases after a year where they “miraculously” disappeared thanks to RT-PCR tests claiming everything was Covid-19.
So we have to ask why is it that it’s important to separate them NOW? What fresh variant is headed our way? What infringements on our liberty do they have in mind? How are they going to gin up fear for a disease that only affects co-morbidities, and even then has an almost 100% recovery rate?
First, stop listening to the bots on social media. Second, follow us for more updates.
Recent MLRT News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 11:48:41 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 07:45:29 PM
- Form 253G1 - • Edgar (US Regulatory) • 08/16/2023 12:23:04 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 08/15/2023 04:15:06 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 09:09:41 PM
- Shares on the Rise Following New Production Announcement for Wearable Monitoring Device Firm • AllPennyStocks.com • 08/10/2023 02:50:00 PM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 08/07/2023 08:50:40 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM